Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
作者： L. Agemy , D. Friedmann-Morvinski , V. R. Kotamraju , L. Roth , K. N. Sugahara
关键词: Molecular biology 、 Oligopeptide 、 Peptide 、 Apoptosis 、 Cell culture 、 Homing (hematopoietic) 、 Iron oxide nanoparticles 、 Angiogenesis 、 Cancer research 、 Chemistry 、 Peptide sequence
摘要: … theranostic nanoparticle in which the CGKRK peptide provides the targeting function that takes the nanoparticles to tumor vascular cells and into their mitochondria. The nanoparticle …
harvard.edu
elsevier.com
sci-hub.se 参考文章(35)
Regina Fillbrandt, Katrin Lamszus, Ulrike Ulbricht, Philip Kunkel, Manfred Westphal, Dimitrios Stavrou, Marc A. Brockmann, Peter Bohlen, Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Research. ,vol. 61, pp. 6624- 6628 ,(2001)
H. Michael Ellerby, Wadih Arap, Lisa M. Ellerby, Renate Kain, Rebecca Andrusiak, Gabriel Del Rio, Stanislaw Krajewski, Christian R. Lombardo, Rammohan Rao, Erkki Ruoslahti, Dale E. Bredesen, Renata Pasqualini, Anti-cancer activity of targeted pro-apoptotic peptides Nature Medicine. ,vol. 5, pp. 1032- 1038 ,(1999) , 10.1038/12469
Napoleone Ferrara, Kari Alitalo, None, Clinical applications of angiogenic growth factors and their inhibitors Nature Medicine. ,vol. 5, pp. 1359- 1364 ,(1999) , 10.1038/70928
Jason A. Hoffman, Enrico Giraudo, Mallika Singh, Lianglin Zhang, Masahiro Inoue, Kimmo Porkka, Douglas Hanahan, Erkki Ruoslahti, Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma Cancer Cell. ,vol. 4, pp. 383- 391 ,(2003) , 10.1016/S1535-6108(03)00273-3
Rakesh K. Jain, Emmanuelle di Tomaso, Dan G. Duda, Jay S. Loeffler, A. Gregory Sorensen, Tracy T. Batchelor, Angiogenesis in brain tumours Nature Reviews Neuroscience. ,vol. 8, pp. 610- 622 ,(2007) , 10.1038/NRN2175
Douglas Hanahan, Judah Folkman, Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis Cell. ,vol. 86, pp. 353- 364 ,(1996) , 10.1016/S0092-8674(00)80108-7
Kaushal Rege, Suraj J. Patel, Zaki Megeed, Martin L. Yarmush, Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells. Cancer Research. ,vol. 67, pp. 6368- 6375 ,(2007) , 10.1158/0008-5472.CAN-06-3658
Rakesh K. Jain, Leonard E. Gerlowski, Eugene V. Cilento, Extravascular transport in normal and tumor tissues Critical Reviews in Oncology Hematology. ,vol. 5, pp. 115- 170 ,(1986) , 10.1016/S1040-8428(86)80023-3
Renata Pasqualini, Erkki Ruoslahti, Organ targeting In vivo using phage display peptide libraries Nature. ,vol. 380, pp. 364- 366 ,(1996) , 10.1038/380364A0
Lilach Agemy, Kazuki N. Sugahara, Venkata Ramana Kotamraju, Kunal Gujraty, Olivier M. Girard, Yuko Kono, Robert F. Mattrey, Ji-Ho Park, Michael J. Sailor, Ana I. Jimenez, Carlos Cativiela, David Zanuy, Francisco J. Sayago, Carlos Aleman, Ruth Nussinov, Erkki Ruoslahti, Nanoparticle-induced vascular blockade in human prostate cancer Blood. ,vol. 116, pp. 2847- 2856 ,(2010) , 10.1182/BLOOD-2010-03-274258